# JUNIPERO THERAPEUTICS, INC.: Epigenetic Silencing of VCP via an ASO-Conjugate Based Induced Proximity System for the Treatment of FTD-ALS in VCP Disease

**Lab Budget Score:** 40/100

| Field | Value |
|---|---|
| Organization | JUNIPERO THERAPEUTICS, INC. |
| Location | KANNAPOLIS, NC |
| Project | Epigenetic Silencing of VCP via an ASO-Conjugate Based Induced Proximity System for the Treatment of FTD-ALS in VCP Disease |
| Project number | 1R41NS150094-01 |
| Mechanism | R41 |
| Institute | National Institute of Neurological Disorders and Stroke |
| Award | $306,872 |
| Awarded | 2026-09-08 |
| Project period | 2026-09-08 to 2027-08-31 |
| UEI | H96WZKBAWJ48 |

## Why this score
- Award of $306,872.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11409656). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.